{
    "organizations": [],
    "uuid": "48e36fb19c003b68deedfd8292d2271fceed2ea7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-alkem-laboratories-announces-closu/brief-alkem-laboratories-announces-closure-of-u-s-fda-inspection-at-baddi-manufacturing-facility-idUSFWN1P504N",
    "ord_in_thread": 0,
    "title": "BRIEF-Alkem Laboratories Announces Closure of U.S.FDA Inspection at Baddi Manufacturing Facility",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 10 (Reuters) - Alkem Laboratories Ltd:\n* SAYS U.S. FDA ISSUES EIR FOR CO‘S MANUFACTURING FACILITY AT BADDI\n* SAYS ‍INSPECTION OF CO‘S MANUFACTURING FACILITY AT BADDI HAS NOW BEEN CLOSED BY US FDA​\n* IN RESPONSE TO TWO FORM 483 OBSERVATIONS ISSUED BY FDA, CO SUBMITTED DETAILED CORRECTIVE AND PREVENTIVE ACTION PLAN TO REGULATOR Source text: bit.ly/2Fm31o5 Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-01-10T17:43:00.000+02:00",
    "crawled": "2018-01-11T12:16:25.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "alkem",
        "laboratory",
        "ltd",
        "say",
        "fda",
        "issue",
        "eir",
        "co",
        "manufacturing",
        "facility",
        "baddi",
        "say",
        "co",
        "manufacturing",
        "facility",
        "baddi",
        "closed",
        "u",
        "response",
        "two",
        "form",
        "observation",
        "issued",
        "fda",
        "co",
        "submitted",
        "detailed",
        "corrective",
        "preventive",
        "action",
        "plan",
        "regulator",
        "source",
        "text",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}